Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.33 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.32 |
| ▸ | CASP3 | P42574 | 1/20 | 0.32 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.32 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.32 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6351424 | 0.83 | ALDH1A1 (0.44) | ATMSMN1; SMN2ALDH1A1KMT2ARXFP1 | |
| SCHEMBL6359904 | 0.81 | ALDH1A1 (0.46) | SMN1; SMN2ALDH1A1KMT2AHPGDRXFP1 | |
| SCHEMBL3780168 | 0.80 | SMN1; SMN2 (0.35) | ATMSMN1; SMN2POLBALDH1A1KMT2A | |
| SCHEMBL22420090 | 0.80 | ALDH1A1 (0.49) | SMN1; SMN2ALDH1A1KMT2AMAPTMEN1 | |
| SCHEMBL13369529 | 0.80 | ALDH1A1 (0.49) | SMN1; SMN2ALDH1A1KMT2AMAPTMEN1 | |
| SCHEMBL3290824 | 0.80 | ALDH1A1 (0.49) | SMN1; SMN2ALDH1A1KMT2AMAPTMEN1 | |
| SCHEMBL10325880 | 0.79 | MAPT (0.41) | ATMSMN1; SMN2POLBALDH1A1L3MBTL1 | |
| SCHEMBL3291388 | 0.77 | ALDH1A1 (0.35) | SMN1; SMN2POLBALDH1A1KMT2AMEN1 | |
| SCHEMBL5526524 | 0.77 | EPHX2 (0.42) | SMN1; SMN2ALDH1A1KMT2AMEN1 | |
| SCHEMBL22115776 | 0.75 | EPHX2 (0.36) | ATMSMN1; SMN2POLBALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2070512-B1 | Methyl cyclohexane carboxylates and their use in perfume compositons | INT FLAVORS & FRAGRANCES INC (US) | 2012-10-31 | — | — | EP | disclosed |
| EP-2070512-B1 | Methyl cyclohexane carboxylates and their use in perfume compositons | INT FLAVORS & FRAGRANCES INC (US) | 2012-10-31 | — | — | EP | disclosed |
| US-7723277-B2 | Methyl cyclohexane carboxylates and their use in perfume compositions | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2010-05-25 | — | — | US | disclosed |
| US-7723277-B2 | Methyl cyclohexane carboxylates and their use in perfume compositions | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2010-05-25 | — | — | US | disclosed |
| US-7723277-B2 | Methyl cyclohexane carboxylates and their use in perfume compositions | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2010-05-25 | — | — | US | disclosed |
| US-20090326079-A1 | METHYL CYCLOHEXANE CARBOXYLATES AND THEIR USE IN PERFUME COMPOSITIONS | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2009-12-31 | — | — | US | disclosed |
| US-20090326079-A1 | METHYL CYCLOHEXANE CARBOXYLATES AND THEIR USE IN PERFUME COMPOSITIONS | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2009-12-31 | — | — | US | disclosed |
| US-20090326079-A1 | METHYL CYCLOHEXANE CARBOXYLATES AND THEIR USE IN PERFUME COMPOSITIONS | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2009-12-31 | — | — | US | disclosed |
| US-7632792-B2 | Methyl cyclohexane carboxylates and their use in perfume compositions | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2009-12-15 | — | — | US | disclosed |
| US-7632792-B2 | Methyl cyclohexane carboxylates and their use in perfume compositions | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2009-12-15 | — | — | US | disclosed |
| US-7632792-B2 | Methyl cyclohexane carboxylates and their use in perfume compositions | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2009-12-15 | — | — | US | disclosed |
| EP-2070512-A1 | Methyl cyclohexane carboxylates and their use in perfume compositons | INTERNATIONAL FLAVORS & FRAGRANCES, INC. (US) | 2009-06-17 | — | — | EP | disclosed |
| EP-2070512-A1 | Methyl cyclohexane carboxylates and their use in perfume compositons | INTERNATIONAL FLAVORS & FRAGRANCES, INC. (US) | 2009-06-17 | — | — | EP | disclosed |
| US-20090131301-A1 | METHYL CYCLOHEXANE CARBOXYLATES AND THEIR USE IN PERFUME COMPOSITIONS | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2009-05-21 | — | — | US | disclosed |
| US-20090131301-A1 | METHYL CYCLOHEXANE CARBOXYLATES AND THEIR USE IN PERFUME COMPOSITIONS | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2009-05-21 | — | — | US | disclosed |
| US-20090131301-A1 | METHYL CYCLOHEXANE CARBOXYLATES AND THEIR USE IN PERFUME COMPOSITIONS | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2009-05-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090326079-A1 | METHYL CYCLOHEXANE CARBOXYLATES AND THEIR USE IN PERFUME COMPOSITIONS | C5, OR51E2, OXER1 | ATM 1385/4885SMN1; SMN2 3039/4885POLB 2368/4885 |
| US-20090131301-A1 | METHYL CYCLOHEXANE CARBOXYLATES AND THEIR USE IN PERFUME COMPOSITIONS | C5, OR51E2, OXER1 | ATM 1385/4885SMN1; SMN2 3039/4885POLB 2368/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.